Clinical Trial Update: Prasugrel Or Ticagrelor De-escalation in NSTE-ACS [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on de-escalation of prasugrel or ticagrelor in NSTEMI/NSTE-ACS patients; status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-segment Elevation Acute Coronary Syndrome
• Non-st-segment Elevation Myocardial Infarction
• Unstable Angina

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: Collegium Medicum w Bydgoszczy | Conditions: Non ST Segment Elevation Acute Coronary Syndrome, Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) | Phase 3 | Status: UNKNOWN